chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Diarrhea; uncontrollable urination; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHEA (Diarrhea) and URINARY INCONTINENCE (uncontrollable urination) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHEA (Diarrhea) and URINARY INCONTINENCE (uncontrollable urination). At the time of the report, DIARRHEA (Diarrhea) and URINARY INCONTINENCE (uncontrollable urination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications was not provided by the reporter Treatment information was not provided
I had a very bad case of Covid last March.  I received my first vaccine March 3 of this year.  I got a temperature of 103 degrees,  I was nourish , my muscles, Joints and bones hurt so much I couldn't lift myself out of bed without extreme pain.  The chills I got made me literally shake.  My arm where I was given the shot, I couldn't lift it.  Even the other arm hurt bad.  My mouth hurt, my teeth hurt, my gums bleed for four days after and the teeth hurt too for that length of time.  My stomach was itchy but no rash.  I felt like I had the virus again minus other issues I had when I did have it.   I'm scheduled to receive my second dose March 31 and I'm very very nervous about it.  I don't think people who had the virus, especially those who had it very bad like myself, should get vaccinated.     It took 2 weeks to recover from all the pain.   HELP!
5 inch x 8 inch eryth, tender, warm spot to (R) thigh.
2nd dose missed (more than 42 days); This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (2nd dose missed (more than 42 days)) in a 32-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.  Concurrent medical conditions included Clotting disorder.  On 11-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jan-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (2nd dose missed (more than 42 days)). On 11-Jan-2021, PRODUCT DOSE OMISSION ISSUE (2nd dose missed (more than 42 days)) had resolved. Not Provided      mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       No concomitant products information is provided   No treatment products information is provided   Most recent FOLLOW-UP information incorporated above includes: On 20-May-2021: Updated reporter email Id, updated patient demographics and changed action taken from unknown to withdrawn.
Head ache; Body Ache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Head ache) and MYALGIA (Body Ache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Head ache) and MYALGIA (Body Ache). At the time of the report, HEADACHE (Head ache) and MYALGIA (Body Ache) outcome was unknown.            All reported events occurred after the second dose of vaccine. No concomitant product was reported.  No treatment information was reported. Action taken with the mRNA-1273 (Moderna COVID-19 Vaccine) is considered as not applicable. Based o current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 12-Mar-2021: Upon internal review on 27-Sep-2022 case level seriousness was updated. On 20-May-2021: Follow up received on 20-May-2021:No new information was provided, FU declined.; Sender's Comments: Based o current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
Dizzy, neck sore and stiffness, itchy tongue , throat and inner ears. felt rapid heart beat and heavy breathing
she is having extreme involuntary movements causing her to make random sounds and thrashing of limbs and head to the point of damaging her body. I have taken her to the doctor she was referred to CT SCAN it was negative we are currently waiting for a call for an appointment with a neurologist.
Narrative:  53yo M died on 4/14/2021 of unknown causes. His problem list included anxiety, depression & knee pain. His med list only included gabapentin, trazodone & prn ibuprofen. Pt mentioned to his provider that he is going to get some medication off the street for his anxiety, depression, & insomnia. Pt had received a covid vaccine (J&J) on 4/6/2021. There is no information available about the circumstances of pt's death. Not able to assess if death related to the vaccine, however events occurred with the week of each other, but pt with mental health issues and self admitted access to "street medications".
This spontaneous report has been received from a licensed practical nurse referring to a 18 year old female patient. The patient did not have pertinent medical history, drug reactions or allergies or concurrent conditions. Concomitant therapies included LYRICA. On 28-JUN-2016, the patient was vaccinated with the first dose of GARDASIL 9 lot # M007728, expiration date 21-MAR-2018 (strength, dose, route and anatomical location were not provided) for prophylaxis. On 15-AUG-2016, the patient received the second dose of GARDASIL 9 lot # M004116, expiration date 12-OCT-2017. Later on 06-JAN-2017, the patient received the third dose of GARDASIL 9 lot # M031557, expiration date 07-APR-2019. The 3 doses were given for prevention of human papilloma virus (HPV). It was reported that on an unspecified dates in 2017 (reported as after the administration of GARDASIL 9 on 06-JAN-2017), the patient began experience "strep throat, sore throats and red throats"; "aches" and fatigue, then the patient developed right lower extremity pain and "limb discomfort" that prevented the patient from "walking and exercising" and "burning in both feet at night". The reporter stated that the patient had been to multiple unspecified doctors including an "autoimmune doctor" who gave her unspecified treatments. On an unknown date in 2017, the patient was prescribed an unspecified antibiotic for "ear, nose and throat" from an unspecified physician. The patient was scheduled for an appointment with physician on 22-SEP-2017. At the reporting time, the outcome of the patient and the causality assessment between therapy with GARDASIL 9 and the events were not reported.
Beet red; Face was on fire; Severe dehydration; Drinking 3-5 times more than normal; Eyes felt like sandpaper; Could not swallow; Severely parched for a month; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Beet red), BURNING SENSATION (Face was on fire), DEHYDRATION (Severe dehydration), POLYDIPSIA (Drinking 3-5 times more than normal) and EYE DISORDER (Eyes felt like sandpaper) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 25-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Beet red), BURNING SENSATION (Face was on fire), DEHYDRATION (Severe dehydration), POLYDIPSIA (Drinking 3-5 times more than normal), EYE DISORDER (Eyes felt like sandpaper), DYSPHAGIA (Could not swallow) and DRY SKIN (Severely parched for a month). At the time of the report, ERYTHEMA (Beet red), BURNING SENSATION (Face was on fire), DEHYDRATION (Severe dehydration), POLYDIPSIA (Drinking 3-5 times more than normal), EYE DISORDER (Eyes felt like sandpaper), DYSPHAGIA (Could not swallow) and DRY SKIN (Severely parched for a month) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No concomitant medication reported.  No treatment medication reported.   This case was linked to MOD-2021-369515, MOD-2021-369515 (Patient Link).
Arm swollen (R) arm from shoulder to elbow - warm to touch, (R) arm 1.5" larger than (L) arm. Started evening of administration very painful.
No adverse event; 3 Moderna COVID-19 vaccines, but received the last dose (Bivalent Booster) Too early; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3 Moderna COVID-19 vaccines, but received the last dose (Bivalent Booster) Too early) and NO ADVERSE EVENT (No adverse event) in a 46-year-old male patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 020H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 06-Jan-2023, the patient received third dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 06-Jan-2023,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3 Moderna COVID-19 vaccines, but received the last dose (Bivalent Booster) Too early). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3 Moderna COVID-19 vaccines, but received the last dose (Bivalent Booster) Too early) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (3 Moderna COVID-19 vaccines, but received the last dose (Bivalent Booster) Too early).    Concomitant medication was not reported.  Patient received Moderna first dose (monovalent) in Oct-2022 (Lot: 011B22A, Exp. Date: unknown) and second dose (monovalent) on 30-Nov-2022 (Lot: 083B22A & Exp. Date: unknown).  Patient received bivalent booster too early. Treatment medication was not reported.
Patient received second dose in a series.  Dose administered was Moderna.  First dose was Pfizer. Second dose was 11+ weeks after first dose.  Pt acknowledges he should have received it sooner.
3 or 4 days after Mr second shot I awoke to a sharp pain on the right side of my chest and underarm that I can only liken to a broken rib. It was excruciating and made breathing very painful for about five days. I could not stay out of bed and had to have my right arm raised over my head when I was not laying in bed. Only lying on my right side somewhat eased the pain. I could not lay in any other position without extreme pain. After about five days of this, the pain began to travel to the right side of my back, finally I was able to breathe without involuntary yelps of pain escaping from me. As more days passed, this severe pain slowly worked its way down my right side and then slowly down to my right thigh, then painfully behind the knee, eventually encompassing my entire leg. Now almost a month later, there are still remnants in my shin. But it's almost gone now, a month later. It never went into my foot.
I received a full dose of the Moderna vaccine for COVID-19 on 9/9/2021. It was my third shot, and it was a full dose rather than a booster, as I have an autoimmune condition. On 6/29/2022, the symptoms of dermatomyosytis returned, and it's a condition whose symptoms I normally am able to manage. The muscles in my legs felt like jelly, and I wasn't able to control them in order to walk normally. Later that night, I developed a severe sore throat. I went to bed. When I woke up on the morning of 6/30/2022, my sore throat was about 75% better, but my muscles continued to feel weak. On that day, I underwent a blood test, and my creatine kinase level was triple its normal level. I went home and did an antigen test for COVID-19, and it showed a very faint line that indicated a positive result. I then went to a PCR testing site and got tested again, and I got a positive result 24 hours later. During the 24 hours I waited for my PCR result, I became very sick. I had extreme weakness and exhaustion. I also had a fever of 102.5. I also experienced a dry cough, plugged ears, and mild nasal congestion. The sore throat that I first developed on 6/29/2022 continued to improve, though, and felt much better. After I got the positive PCR result, I tried to get monoclonal antibodies, as they had been recommended to me by my doctor. Unfortunately, the staff at the urgent care clinic I went to decided that I was not a candidate, despite the urging of my physician. I ultimately was prescribed Paxlovid, though, and within 24 hours after taking it, I started feeling better. My fever went down to 100 degrees, my energy returned, and I regained my appetite. I continued to get better and by 7/5/2022, I got a negative result on a home test.
I had joint pain, rash on arm, fever, heart palpitations, chest pain, nausea, flu like symptoms and brain fog.
This spontaneous report as received from a pharmacist refers to a patient of unknown age and gender. On 28-OCT-2013 the patient was vaccinated with ZOSTAVAX (route and dose unknown) lot # J001729 dose 1. On 28-OCT-2013 the patient received expired ZOSTAVAX. No adverse symptoms reported. Additional information has been requested.
Headache, fever, and red, firm, itchy swelling at injection site. Took advil and use cortisone.
Affecting breathing; Shoulder and neck hurting; Shoulder and neck hurting; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot Number: unknown), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On an unspecified date, the patient came fine while they gave the Pfizer shot, it did not hurt but it was affecting breathing and shoulder and neck hurting. Consumer stated that patient did not know if its normal, was it affect shoulder and neck, breathing and got it this morning. The outcome of events was unknown.  Information on the lot/batch number has been requested.
Fever of 102F 7 days after MMR vaccine. Rash 10 days after MMR vaccine. Fine, small red dots, all over trunk, legs and buttock, cheeks flushed.
About 8 hours after receiving the SHINGRIX vaccination, my entire body suddenly felt freezing, calling it chills or shivering is an understatement. It was more like I was sitting inside my refrigerator with the door closed for 5 minutes, then let out for 25 minutes, then returned to the refrigerator for 5 minutes, then let out for 25 minutes, and so on every half hour for about 9 hours. Even trying to sleep while wearing a shirt and 3 sweatshirts, plus sweatpants, and long thick socks under three comforters on my bed did not ease the freezing sensation. It also sent my insomnia into overdrive: I felt as if I had had 6 espressos intravaneously injected, as I was unable to sleep for at least 17 hours. After about 12 hours, the nausea set in; after trying to drink 1/3 of a cup of a light green tea, I vomited. I also had body aches and a sore arm (similar to soreness after receiving a tetanus vaccination), but those were elements I expected. I am reporting this so others can be more approriately warned of possible side effects. I eventually was able to sleep for 13 hours solid, after which, on 2/2/19, I felt more normal I still had the achiness and soar arm, but the other symptoms went away.
pt recvd vax & exp a raised, irritated body rash;pt was seen by MD who treated rash w/pred;
RECEIVED CALL FROM PT. SHE HAD HER 2ND MODERNA VACCINE 1/25 IN THE OFFICE. STATES WOKE UP AROUND 2AM WITH TERRIBLE HEADACHE, AND THEN AS MORNING PROGRESSED, SHE NOTICED SWELLING OF THE RIGHT SIDE OF HER FACE.  EXTENDS FROM JAW UP ALONG NOSE AND BACK TO MID CHEEK.  STATE SHE FEELS FINE OTHERWISE. STATES SHE WHEN SHE SMILES BOTH SIDE OF MOUTH TURN UP, NO LOSS OF SENSATION.  PT STATES SHE DOES NOT HAVE SMART PHONE AND CANNOT FILL OUT VSAFE INFO, NO COMPUTER AT HOME EITHER.  ASKED PT IF THIS RN CAN FILL OUT VAERS ON  HER BEHALF. PT AGREEABLE.
Localized cellulitis at injection site developed the day following vaccine administration treated with Keflex x 10 days.
t103.5 12 hrs p/vax given; fever down to 101 w/in 24 hrs but present x 5 days; 8AUG91 devel "rash across face, body & buttocks"; MD visit 16AUG91 dx OM & staph infect of skin; Rash gone p/24 hrs on ATB;
pt recv vax & 4DEC96 exp three bouts of sl fever, devel a blank stare, woke up 3x & exp one bout of diarrhea;the next morning pt was different & by the late morning pt was OK;
Immediately after injection, I experienced rapid heart rate, dizziness and nausea. About an hour after the injection, I had a fever, chills, body aches, headache, nausea and extreme fatigue that lasted for 5 days straight. Then, 10 days after the injection, my entire upper left arm (injection arm) became raised, inflamed, red and sensitive to touch.
pt recv vax 20MAY97 & returned to office 22MAY97 w/a red,hot, swollen lt leg-mottled in color & sore to touch;would not walk on it 21MAY97 evening but was walking on it when seen;
purple-bluish to black blister in the skin of left hand; numb-ish in hand; A spontaneous report was received from a consumer concerning a female patient of unknown age, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced blister and numbness in hand. The patient's medical history was not provided. No relevant concomitant medications were reported.  On 03 Mar 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: unknown) intramuscularly in the left arm for prophylaxis of COVID-19 infection.  On 03 Mar 2021, the patient experienced purple-bluish to black blister in the skin of left hand and numb-ish in hand. Laboratory details was not provided.No treatment information was provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, blister and numbness in hand was considered as unknown at the time of report.
Approximately 24 hours after dose given, developed debilitating pain in joints and muscles, temp spiked to 103,  developed mouth sores in side mouth and on tongue, extreme headache, tops of feet and hands became numb, cramping and tingling in all extremities, chest tightness, unable to ambulate for 6 hours. Have had debilitating headaches every morning since dose, Brain fog, developed bells palsy on L side of face approximately 2 weeks after does, lost hearing in left ear, started with blurred vision in my l eye, started having POTS syndrome, dizzy and falling when standing from lying and sitting position, increased anxiety, increased fatigue, malaise and increased body pain, increased palpitations, difficulty concentrating, daily fevers, neuropathy, chronic swelling of L ankle, post exertional malaise ( mental and physiccal exertion)
Diffuse body rash with red spots on face, chest, back, arms, legs. Increased swelling of bilateral legs.   Leg swelling first started in the afternoon after the vaccine, followed by diffuse rash with mild itching at night. The rash was on the arms and then spread to the rest of the body  The patient had been taking benadryl at night with improvement of her rash .   No respiratory complaints
Blood clot; This is a spontaneous report from a contactable healthcare professional and a physician.  A patient of unspecified age and gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number/expiration date not reported), via an unspecified route of administration on an unspecified date as unknown, single for COVID-19 immunization. Medical history and concomitant medications were not reported. The reporter had a patient who may have had a possible side effect. It was reported that the patient may be experiencing a blood clot on an unspecified date. The reporter wanted further direction on whether or not an anticoagulant can be given. Anatomical location of blood clot is unknown. The outcome of the event was unknown.   Information on the batch/lot number has been requested.; Sender's Comments: Based on available information, a possible contributory role of BNT162B2 vaccine can not be excluded for the reported event of blood clot due to temporal relationship.  Case will be re-assessed upon the additional information provided. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.
Extreme nausea and vomiting, mild diarrhea.  Lasted for 18 hours.  Did not seek medical advice,  just waited it out.
Muscle soreness in both arms, painful injection site, red and swollen injection site after 9 days
no other adverse event; patient received a dose of Gardasil 9 after it was stored outside of the recommended storage range; This spontaneous report was received from a medical assistance and refers to a patient of unknown age and gender. The patient's pertinent medical history, drug reactions, allergies and concomitant medications were not provided.  On 30-OCT-2020, the patient was vaccinated with an improperly stored one dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) lot # S031287, expiration dare 08-APR-2022 for prophylaxis (exact dose, dose #, route of administration and anatomical location were not provided).  The temperature excursion was 8.6 Celsius degree for 9 hours and 10 minutes. There were no previous excursions reported. The digital data logger was involved. No adverse event were reported. combinationproductreport: Yes; brandname: GARDASIL 9 SYRINGE (DEVICE); commondevicename: HPV rL1 6 11 16 18 31 33 45 52 58 VLP vaccine (yeast); productcode: FMF; devicetype: SYRINGE, PISTON (FMF); manufacturername: Merck Sharp & Dohme Corp.; devicelotnumber: S031287; expirationdate: 08-APR-2022; deviceage and unit: 0 ; malfunction: Unknown; deviceusage: Initial; evaluatedbymfr: Not returned to manufacturer; reasonfornoneval: 81 Other; labeledsingleusedevice: No; mdcpreportability: No; mdcpreprationale: Case information does not suggest a causal association with the device or device constituent